Trametinib suppresses HIV-1 replication by interfering with the disassembly of human immunodeficiency virus type 1 capsid core
Authors:
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 495 (2) , 1846-1850
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (15H04659)
This publication has 13 references indexed in Scilit:
- Negative feedback regulation of the ERK1/2 MAPK pathwayCellular and Molecular Life Sciences, 2016
- MEK1 and MEK2 inhibitors and cancer therapy: the long and winding roadNature Reviews Cancer, 2015
- Phosphorylation of human immunodeficiency virus type 1 capsid protein at serine 16, required for peptidyl-prolyl isomerase-dependent uncoating, is mediated by virion-incorporated extracellular signal-regulated kinase 2Journal of General Virology, 2014
- Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancersNature, 2013
- Mechanism of Host Cell MAPK/ERK-2 Incorporation into Lentivirus Particles: Characterization of the Interaction between MAPK/ERK-2 and Proline-Rich-Domain Containing Capsid Region of Structural Protein GagJournal of Molecular Biology, 2011
- Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1Journal of Biological Chemistry, 2010
- Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5α restriction factorProceedings of the National Academy of Sciences, 2006
- Evaluation of the Functional Involvement of Human Immunodeficiency Virus Type 1 Integrase in Nuclear Import of Viral cDNA during Acute InfectionJournal of Virology, 2004
- Potential roles of cellular proteins in HIV‐1Reviews in Medical Virology, 2002
- Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinaseThe EMBO Journal, 1997